Bangor Savings Bank’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.43M Buy
3,708
+14
+0.4% +$5.19K 0.11% 82
2026
Q1
$1.08M Sell
3,694
-94
-2% -$30.9K 0.09% 93
2025
Q4
$1.33M Sell
3,788
-597
-14% -$202K 0.11% 85
2025
Q3
$1.42M Sell
4,385
-25
-0.6% -$7.78K 0.12% 82
2025
Q2
$1.72M Sell
4,410
-192
-4% -$77.2K 0.15% 67
2025
Q1
$2M Sell
4,602
-86
-2% -$34.5K 0.19% 59
2024
Q4
$1.73M Sell
4,688
-144
-3% -$60.3K 0.16% 73
2024
Q3
$2.51M Sell
4,832
-184
-4% -$98.3K 0.24% 50
2024
Q2
$2.72M Sell
5,016
-132
-3% -$69.8K 0.27% 42
2024
Q1
$2.67M Sell
5,148
-228
-4% -$113K 0.27% 42
2023
Q4
$2.54M Buy
5,376
+46
+0.9% +$21.3K 0.28% 48
2023
Q3
$2.32M Sell
5,330
-106
-2% -$48.1K 0.28% 47
2023
Q2
$2.42M Buy
5,436
+33
+0.6% +$15.2K 0.27% 45
2023
Q1
$2.48M Sell
5,403
-28
-0.5% -$13.3K 0.29% 40
2022
Q4
$2.79M Sell
5,431
-399
-7% -$203K 0.33% 34
2022
Q3
$2.65M Sell
5,830
-48
-0.8% -$23K 0.31% 36
2022
Q2
$2.84M Buy
+5,878
New +$2.91M 0.31% 38
2022
Q1
Sell
-6,026
Closed -$2.79M 197
2021
Q4
$2.79M Sell
6,026
-7
-0.1% -$2.94K 0.27% 47
2021
Q3
$2.25M Buy
6,033
+244
+4% +$92.7K 0.23% 57
2021
Q2
$2.21M Sell
5,789
-337
-6% -$129K 0.25% 52
2021
Q1
$2.2M Buy
6,126
+82
+1% +$26.4K 0.27% 47
2020
Q4
$1.94M Buy
6,044
+927
+18% +$284K 0.26% 49
2020
Q3
$1.37M Sell
5,117
-1,875
-27% -$505K 0.21% 67
2020
Q2
$1.84M Sell
6,992
-12
-0.2% -$3.2K 0.3% 45
2020
Q1
$1.59M Buy
7,004
+72
+1% +$19.6K 0.3% 46
2019
Q4
$2.09M Buy
6,932
+286
+4% +$78.7K 0.33% 42
2019
Q3
$1.6M Sell
6,646
-72
-1% -$19.7K 0.27% 52
2019
Q2
$1.9M Sell
6,718
-141
-2% -$38.5K 0.33% 39
2019
Q1
$1.97M Sell
6,859
-307
-4% -$88.8K 0.37% 38
2018
Q4
$1.88M Sell
7,166
-692
-9% -$190K 0.39% 37
2018
Q3
$2.15M Sell
7,858
-273
-3% -$70.9K 0.4% 37
2018
Q2
$1.94M Sell
8,131
-240
-3% -$55.6K 0.37% 41
2018
Q1
$1.84M Sell
8,371
-442
-5% -$104K 0.36% 43
2017
Q4
$1.98M Sell
8,813
-241
-3% -$51.3K 0.39% 40
2017
Q3
$1.72M Buy
+9,054
New +$1.72M 0.35% 49
2017
Q2
Sell
-11,215
Closed -$1.85M 142
2017
Q1
$1.85M Buy
11,215
+4,047
+56% +$644K 0.41% 47
2016
Q4
$1.03M Sell
7,168
-26
-0.4% -$3.48K 0.24% 72
2016
Q3
$902K Sell
7,194
-83
-1% -$10.7K 0.22% 77
2016
Q2
$956K Buy
7,277
+26
+0.4% +$3.56K 0.24% 71
2016
Q1
$1.01M Buy
7,251
+14
+0.2% +$1.87K 0.25% 72
2015
Q4
$1.01M Buy
7,237
+58
+0.8% +$7.99K 0.25% 71
2015
Q3
$1M Buy
7,179
+91
+1% +$13.7K 0.26% 68
2015
Q2
$1.16M Sell
7,088
-605
-8% -$96.7K 0.28% 65
2015
Q1
$1.19M Sell
7,693
-176
-2% -$25.1K 0.29% 68
2014
Q4
$989K Buy
7,869
+151
+2% +$18.7K 0.25% 74
2014
Q3
$923K Sell
7,718
-553
-7% -$63.4K 0.25% 72
2014
Q2
$890K Buy
+8,271
New +$852K 0.23% 74

Other funds holding ELV

Bangor Savings Bank's ELV Position: Q2 2026 in Review

Bangor Savings Bank increased its Elevance Health (ELV) stake by 0.38% in Q2 2026, buying an estimated $5.19K and bringing the position to 3,708 shares worth $1.43M. The position accounts for 0.11% of the portfolio, ranked #82.

Bangor Savings Bank first reported a position in ELV in Q2 2014 and has held it in 47 quarters since. The position peaked at $2.84M in Q2 2022. 417 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Bangor Savings Bank held 3,708 shares of Elevance Health worth $1.43M as of Q2 2026.
  • Bangor Savings Bank bought 14 Elevance Health shares in Q2 2026, an estimated $5.19K.
  • Elevance Health made up 0.11% of Bangor Savings Bank's portfolio in Q2 2026, its #82 holding.
  • Bangor Savings Bank first reported a position in Elevance Health in Q2 2014 and has held it in 47 quarters since.
  • Bangor Savings Bank's Elevance Health position peaked at $2.84M in Q2 2022.
  • 417 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Bangor Savings Bank's 13F filing for Q2 2026, filed 6 Jul 2026.